Manténgase sano!

Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.

In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but th...

Elon Musk, co-founder of Neuralink, said this week that the company placed the first brain implant in a human over the weekend.

In a statement posted on X, the platform formerly known as Twitter that is now owned by Musk, the billionaire said the patient was "recovering well."He added that "ini...

New research is helping confirm smoking as a risk factor for the devastating brain illness amyotrophic lateral sclerosis (ALS).

ALS affects roughly 31,000 Americans each year, with about 5,000 new cases diagnosed annually, according to the U.S. Centers for Disease Control and Prevention. It's a progressive, fatal illness that causes nerves cells controlling muscles to slowly die, leading ...

Amyotrophic lateral sclerosis, better known as ALS, is debilitating and has no cure.

Now, researchers at the University of Michigan have developed an environmental risk score that will allow them to assess a person's risk for developing ALS, as well as their survival after diagnosis.

Toxins such as pesticides and carcinogenic PCBs affect a person's risk of developing and dying from ...

An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS.

Although the FDA isn't bound by the votes of its advisory panels, agency scientists have already penned a scathing review of the drug, called NuOwn.

Th...

Many Medicare patients can't get help close to home for brain and nervous system issues.

Nearly 1 in 5 Medicare recipients in the United States live at least 50 miles from their neurologist.

"Our study found a substantial travel burden exists for some people with neurologic conditions, including people living in areas with fewer neurologists and rural areas,"said study author

Many people with Lou Gehrig's disease, also called amyotrophic lateral sclerosis (ALS), first start to lose the ability to move their arms and legs.

That's not Pat Bennett. She can move just fine. She can still dress herself, and she can even use her fingers to type.

But ALS has robbed Bennett, 68, of her ability to speak. She can no longer use the muscles of her lips, tongue, laryn...

Dentures may hide harmful germs that cause pneumonia, British researchers report.

For the study, the investigators took samples from the dentures of nursing home patients who did and didn't have pneumonia. They analyzed the samples to identify the types of microbes present. The researchers specifically looked for microbes that could cause pneumonia and if there were significant differenc...

Consuming omega-3 fatty acids like flaxseed oil and walnuts may help slow the decline in physical function related to amyotrophic lateral sclerosis (ALS), new research suggests.

ALS (formerly known as Lou Gehrig's disease) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. People with ALS lose the ability to initiate and control muscle moveme...

The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

The medication, toferson (Qalsody), targ...

People with cerebral palsy are more likely to be prescribed opioids to manage pain, making them vulnerable to the ongoing opioid crisis in the United States, according to a new study.

While pain is common among patients with cerebral palsy, opioids may not be as helpful for them because their pain is complex, researchers say.

Yet,